Article Details
Retrieved on: 2021-04-20 10:07:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... partner Kedrion Biopharma are forging ahead with the development of a new anti-Covid therapy derived from the plasma of convalescent patients.
Article found on: www.prnewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here